Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-19

Clinical Trial Update: Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

View source ↗

Summary

An observational study evaluating functional benign prostatic hyperplasia symptoms in patients who switched from phytotherapy to ALNA (tamsulosin) has been comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALNA (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Status: COMPLETED